Search results
FDA must fix “inadequate” inspection and recall policies, report says
Just Food via Yahoo Finance· 1 day agoSome of those metrics included boosting the FDA's number of inspections, shortening the time it...
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate· 2 days agoThe FDA will officially vote Aug. 11 on whether to approve the treatment. The agency isn’t required...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 1 day agoThis is appealing to people who are uneasy with the newer mRNA technology. But the competitor...
Scilex's SP-102 shows promise for sciatica pain relief By Investing.com
Investing.com· 10 hours agoThe study findings, featured in PAIN, the official journal of the International Association for the...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 2 days ago"FDA approves AstraZeneca’s Farxiga for paediatric T2D patients" was originally created and...
Some Hawking Stem Cells Say They Can Treat Almost Anything. They Can't
US News & World Report· 19 minutes agoThe mailings promised “Life Without Pain!” via stem cell injections or IVs administered in a patient’s own home. The allure was obvious: more than 20% of U.S. adults endure chronic pain. The ...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks· 24 hours agoAn FDA panel endorses Eli Lilly's (LLY) Alzheimer's disease drug, donanemab. Pfizer's (PFE) DMD study on investigational gene therapy fails.
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate via Yahoo News· 2 days agoIf the FDA approves Lykos’ application in August, it would be the first time in the agency’s history...
FDA approves first RSV vaccine for use in at-risk adults over 50
The Hill via Yahoo News· 7 days agoThe Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial...
FDA Approves Expansion of Treatment Area for AK Treatment
Medscape· 4 days agoApproval was based on a phase 3, open-label study of adults with AKs.